Published in Transplantation on April 27, 2010
Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J Am Soc Nephrol (2012) 1.44
Glucose metabolism after renal transplantation. Diabetes Care (2013) 0.99
ENPP1/PC-1 K121Q and other predictors of posttransplant diabetes. Metab Syndr Relat Disord (2010) 0.82
Metabolic syndrome, vitamin D deficiency and hypoadiponectinemia among nondiabetic patients early after kidney transplantation. Am J Nephrol (2013) 0.78
The impact of abnormal glucose regulation on arterial stiffness at 3 and 15 months after kidney transplantation. Diabetol Metab Syndr (2014) 0.76
Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for management. World J Diabetes (2015) 0.76
Association of Inflammation prior to Kidney Transplantation with Post-Transplant Diabetes Mellitus. Cardiorenal Med (2016) 0.75
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998) 46.95
Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22
Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care (2003) 29.49
Standards of medical care in diabetes--2006. Diabetes Care (2006) 9.56
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes (1997) 8.96
Diagnosis and classification of diabetes mellitus. Diabetes Care (2006) 7.91
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med (2002) 6.32
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54
Diabetes mellitus after kidney transplantation in the United States. Am J Transplant (2003) 4.39
Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes (2003) 2.76
Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int (2002) 2.10
Trends in waist circumference among U.S. adults. Obes Res (2003) 2.01
MDRD equations for estimation of GFR in renal transplant recipients. Am J Transplant (2005) 1.82
New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int (2005) 1.73
Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM). Nephrol Dial Transplant (2008) 1.63
Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation (2003) 1.62
Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol (2000) 1.60
The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int (2006) 1.57
Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation (1997) 1.07
Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. Am J Transplant (2004) 1.07
Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis (2006) 1.03
Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation. Transpl Int (2008) 1.01
The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon. Transplantation (2006) 0.96
Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study. J Am Soc Nephrol (2001) 0.95
Should an oral glucose tolerance test be performed routinely in all renal transplant recipients? Clin J Am Soc Nephrol (2005) 0.94
Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. Am J Transplant (2008) 0.93
Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. Nephrol Dial Transplant (2001) 0.93
Metabolic cardiovascular syndrome after renal transplantation. Nephrol Dial Transplant (2001) 0.92
Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression. J Am Soc Nephrol (2002) 0.89
Metabolic syndrome treatment strategies. Pharmacotherapy (2006) 0.80
Mechanism of the diabetogenic action of cyclosporin A. Horm Metab Res (1998) 0.80
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA (2005) 4.16
Fluid overload at initiation of renal replacement therapy is associated with lack of renal recovery in patients with acute kidney injury. Nephrol Dial Transplant (2011) 1.96
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant (2004) 1.90
Cardiovascular complications after renal transplantation and their prevention. Transplantation (2006) 1.86
A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol (2013) 1.72
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int (2013) 1.69
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl (2009) 1.69
Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Geriatr Soc (2002) 1.49
Oxidative Balance Score and Chronic Kidney Disease. Am J Nephrol (2015) 1.42
Periodontal disease and other nontraditional risk factors for CKD. Am J Kidney Dis (2008) 1.32
CKD progression and mortality among older patients with diabetes. Am J Kidney Dis (2005) 1.24
New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression. Transplantation (2011) 1.10
Six-month prophylaxis is cost effective in transplant patients at high risk for cytomegalovirus infection. J Am Soc Nephrol (2009) 1.06
Timing of dialysis initiation in transplant-naive and failed transplant patients. Nat Rev Nephrol (2012) 1.04
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Kidney Int (2009) 1.03
Gender imbalance and outcomes in living donor renal transplantation in the United States. Am J Transplant (2003) 0.99
Organ donation in the United States. Am J Transplant (2003) 0.98
Risk factors for peripheral arterial disease among patients with chronic kidney disease. Am J Cardiol (2012) 0.94
Estimated glomerular filtration rate at reinitiation of dialysis and mortality in failed kidney transplant recipients. Nephrol Dial Transplant (2012) 0.93
Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: a 10-year national cohort study. J Heart Lung Transplant (2007) 0.90
Early pancreas graft failure is associated with inferior late clinical outcomes after simultaneous kidney-pancreas transplantation. Transplantation (2011) 0.89
Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort). J Am Coll Cardiol (2013) 0.88
Transition from donor candidates to live kidney donors: the impact of race and undiagnosed medical disease states. Clin Transplant (2011) 0.87
Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitus. Transplantation (2007) 0.81
Metabolic syndrome, vitamin D deficiency and hypoadiponectinemia among nondiabetic patients early after kidney transplantation. Am J Nephrol (2013) 0.78
Meeting the challenge to improve the treatment of hypertension in blacks. J Clin Hypertens (Greenwich) (2003) 0.77
Universal prophylaxis is cost effective in cytomegalovirus serology-positive kidney transplant patients. Transplantation (2011) 0.77
Evaluation of a transplantation specialty pharmacy program. Am J Health Syst Pharm (2012) 0.77
Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression. Pharmacotherapy (2009) 0.76
Evaluation of pancreatic allograft dysfunction by laparoscopic biopsy. Transplantation (2002) 0.76
Influence of reporting methods of outcomes across transplant centers. Clin J Am Soc Nephrol (2011) 0.75
Serum Bicarbonate and Structural and Functional Cardiac Abnormalities in Chronic Kidney Disease - A Report from the Chronic Renal Insufficiency Cohort Study. Am J Nephrol (2016) 0.75
The time interval between kidney and pancreas transplantation and the clinical outcomes of pancreas after kidney transplantation. Clin Transplant (2011) 0.75
The Impact of Obesity on Allograft Failure After Kidney Transplantation: A Competing Risks Analysis. Transplantation (2016) 0.75
Antifungal Prophylaxis in Lung Transplant Recipients. Transplantation (2016) 0.75
Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease. Am J Nephrol (2017) 0.75